These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 18079025)
41. APOE, vascular pathology, and the AD brain. Yip AG; McKee AC; Green RC; Wells J; Young H; Cupples LA; Farrer LA Neurology; 2005 Jul; 65(2):259-65. PubMed ID: 16043796 [TBL] [Abstract][Full Text] [Related]
42. Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation. Yilmazer-Hanke DM; Hanke J Dement Geriatr Cogn Disord; 1999; 10(2):70-6. PubMed ID: 10026378 [TBL] [Abstract][Full Text] [Related]
43. Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans. Dickson DW; Davies P; Bevona C; Van Hoeven KH; Factor SM; Grober E; Aronson MK; Crystal HA Acta Neuropathol; 1994; 88(3):212-21. PubMed ID: 7810292 [TBL] [Abstract][Full Text] [Related]
49. Meta-analysis of postmortem studies of Alzheimer's disease-like neuropathology in schizophrenia. Baldessarini RJ; Hegarty JD; Bird ED; Benes FM Am J Psychiatry; 1997 Jun; 154(6):861-3. PubMed ID: 9167518 [TBL] [Abstract][Full Text] [Related]
50. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. Newell KL; Hyman BT; Growdon JH; Hedley-Whyte ET J Neuropathol Exp Neurol; 1999 Nov; 58(11):1147-55. PubMed ID: 10560657 [TBL] [Abstract][Full Text] [Related]
51. [Expression of apolipoprotein E in Alzheimer's disease and its significance]. He SR; Liu DG; Wang S; Xia YJ Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304 [TBL] [Abstract][Full Text] [Related]
52. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882 [TBL] [Abstract][Full Text] [Related]
53. Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older. Berg L; McKeel DW; Miller JP; Baty J; Morris JC Arch Neurol; 1993 Apr; 50(4):349-58. PubMed ID: 8460956 [TBL] [Abstract][Full Text] [Related]
54. Alzheimer's disease, cerebral amyloid angiopathy, and dementia of acute onset. Lopez O; Claassen D; Boller F Aging (Milano); 1991 Jun; 3(2):171-5. PubMed ID: 1911906 [TBL] [Abstract][Full Text] [Related]
55. Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer's disease. Nicoll JAR; Buckland GR; Harrison CH; Page A; Harris S; Love S; Neal JW; Holmes C; Boche D Brain; 2019 Jul; 142(7):2113-2126. PubMed ID: 31157360 [TBL] [Abstract][Full Text] [Related]
56. Neuropathological criteria for the diagnosis of Alzheimer's disease. Markesbery WR Neurobiol Aging; 1997; 18(4 Suppl):S13-9. PubMed ID: 9330980 [TBL] [Abstract][Full Text] [Related]
57. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients. Montine TJ; Markesbery WR; Zackert W; Sanchez SC; Roberts LJ; Morrow JD Am J Pathol; 1999 Sep; 155(3):863-8. PubMed ID: 10487843 [TBL] [Abstract][Full Text] [Related]